Priming Human Mesenchymal Stromal Cells to Enhance their Regenerative Potential

@inproceedings{Rashedi2017PrimingHM,
  title={Priming Human Mesenchymal Stromal Cells to Enhance their Regenerative Potential},
  author={Iran Rashedi},
  year={2017}
}
MSCs show promise for cell therapy due to their immune-suppressive and regenerative properties. Consequently, MSCs have been widely used in an increasing number of clinical trials to treat a variety of pathological conditions including cardiovascular diseases and disorders with dysregulated immune function. The outcome of prospective MSC therapy trials however, has shown marginal benefit warranting further investigation to develop strategies to enhance their therapeutic potential. The latter… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 413 REFERENCES

Toll-Like Receptors and Myocardial Inflammation

  • International journal of inflammation
  • 2011
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Cytokine secretion profiling of human mesenchymal stem cells by antibody array.

  • International journal of stem cells
  • 2009
VIEW 17 EXCERPTS
HIGHLY INFLUENTIAL

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

K Le Blanc, F Frassoni, L Ball
  • 2008
VIEW 10 EXCERPTS
HIGHLY INFLUENTIAL

The role of pattern-recognition receptors in graftversus-host disease and graft-versus-leukemia after allogeneic stem cell transplantation

S Heidegger, MR van den Brink, T Haas
  • Front Immunol
  • 2014
VIEW 10 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…